Top compounds associated with response to B9D2


Feature Type Standardized
Nominal ANOVA
mRNA ATRA GDSC1000 pan-cancer AAC 0.096 0.006
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.007
mRNA Axitinib CTRPv2 pan-cancer AAC 0.097 0.007
mRNA GSK-650394 GDSC1000 pan-cancer AAC 0.097 0.007
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.098 0.007
mRNA tacrolimus CTRPv2 pan-cancer AAC 0.1 0.007
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.099 0.008
mRNA FTI-277 GDSC1000 pan-cancer AAC -0.092 0.008
mRNA Sorafenib CCLE pan-cancer AAC 0.13 0.008
mRNA trifluoperazine CTRPv2 pan-cancer AAC -0.11 0.009
Download CSV